- Home
- SEIC vs RGC Comparison
SEIC vs RGC Comparison
Compare SEIC & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SEIC | RGC |
|---|---|---|
| Founded | 1968 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.0B | 11.5B |
| IPO Year | 1995 | 2020 |
Fundamental Metrics
Financial Performance| Metric | SEIC | RGC |
|---|---|---|
| Price | $87.69 | $6.12 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $104.86 | N/A |
| AVG Volume (30 Days) | ★ 592.8K | 201.0K |
| Earning Date | 04-22-2026 | 10-31-2025 |
| Dividend Yield | ★ 1.14% | N/A |
| EPS Growth | ★ 27.66 | N/A |
| EPS | ★ 1.40 | N/A |
| Revenue | ★ $2,297,381,000.00 | N/A |
| Revenue This Year | $14.61 | N/A |
| Revenue Next Year | $7.25 | N/A |
| P/E Ratio | $61.76 | ★ N/A |
| Revenue Growth | ★ 8.10 | N/A |
| 52 Week Low | $75.08 | $5.80 |
| 52 Week High | $93.96 | $69.00 |
Technical Indicators
Market Signals| Indicator | SEIC | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 46.57 | 14.99 |
| Support Level | $87.57 | N/A |
| Resistance Level | $92.43 | $15.80 |
| Average True Range (ATR) | 2.05 | 2.19 |
| MACD | -0.34 | -0.86 |
| Stochastic Oscillator | 33.11 | 2.80 |
Price Performance
Historical ComparisonAbout SEIC SEI Investments Company
SEI Investments provides investment processing, management, and operations services to financial institutions, asset managers, asset owners, and financial advisors in four material segments: private banks, investment advisors, institutional investors, and investment managers. SEI also has a minority interest in LSV Asset Management, a value equity asset manager with about $99 billion in assets under management. As of December 2025, SEI (including LSV) manages, administers, or advises about $1.9 trillion in assets.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.